The third Novartis Social Business stakeholder dialogue, co-hosted this year with Novartis Oncology, will bring together a cross-section of stakeholders in Basel on November 21. They will discuss opportunities and innovations that will define the future of access programs and social business models in developing countries.
The event will be an opportunity to reflect on how access models have helped deliver better healthcare for populations living at the base of the pyramid – including key hurdles and achievements, and how learnings can help define next steps. It will also provide perspectives on how innovative partnerships, inclusive business approaches, digital health, impact investment and local solutions can help shape the future of access to healthcare in lower-income countries.
Speakers and panelists will include a broad spectrum of representatives from patient groups, think tanks, private foundations and healthcare practitioners, including The Max Foundation, the Ethiopian Red Cross, FSG, Allied World Healthcare, Bamboo Capital Partners, the Cameroonian Society of Cardiology, the Medtronic Foundation, and the Myanmar Health and Development Consortium.
Exploring the future of access to healthcare in lower-income countries: what will drive success?
November 21, 2017
09:30 – 15:30 CET
Basel, Novartis campus
Participation is free of charge but registration is required as places are limited.
A highlights video and full versions of each keynote speech and panel discussion will be made available shortly after the event.
Follow the discussion on twitter: #talkingNCDs
Novartis Social Business stakeholder dialogue events on access to healthcare
All our Novartis Social Business programs take a “learn by doing” approach as we look for new and better ways to expand access to healthcare in lower-income settings. As part of that, we are committed to transparency and dialogue – and our series of stakeholder events endeavors to do just that.
Find out more about the previous events: